National Storage Mechanism | Additional information
RNS Number : 3438J
StoneX Group Inc.
24 October 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

StoneX Group Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

StoneX Group Inc.

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

     The latest practicable date prior to the disclosure

23 October 2024

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Common Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

     TOTAL:

Nil

Nil

Nil

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions.

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b)        Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a)  Interests held by directors of StoneX Group Inc. and their close relatives and related trusts

 

Name

No. of common shares in StoneX Group Inc

Percentage of total issued share capital*

Sean O'Connor**

1,761,926

5.53

Annabelle Bexiga

6,475

0.02

Diane L Cooper

10,254

0.04

John M Fowler**

80,186

0.26

Steven Kass

17,118

0.06

Eric Parthemore

14,985

0.05

John Radziwill**

695,791

2.19

Dr Dhamu Thamodaran

18,040

0.06

 

* Figures are truncated at two decimal places.

 

** Includes interests held by close relatives and related trusts.

 

(b)  Interests held as options or awards under the share plans of StoneX Group Inc. by the directors of StoneX Group Inc. and their close relatives and related trusts who are not exempt principal traders for the purposes of Rule 8 of the Code

 

(i) Stock options

 

Name

No. of common shares in StoneX Group Inc. under option or subject to award

Date of grant

Exercise price

Vesting date

Expiry date

Sean O'Connor

300,000

13/02/19

$30.00

Options vest in equal proportions on each of the 3rd, 4th, 5th, 6th and 7th anniversaries of the grant date.

05/12/26

Sean O'Connor

300,000

05/12/23

$64.25

Options vest in equal proportions on each of the 3rd, 4th, 5th, 6th and 7th anniversaries of the grant date.

05/12/31

Sean O'Connor

150,000

21/12/23

$71.35

Options vest in equal proportions on each of the 3rd, 4th, 5th, 6th and 7th anniversaries of the grant date.

05/12/31

 

(ii) Restricted stock

 

Name

No. of common shares in StoneX Group Inc. under option or subject to award

Date of grant

Exercise price

Vesting date

Expiry date

Sean O'Connor

6,072

15/12/21

$0.00

15/12/24

None

9,099

15/12/22

$0.00

15/12/24

None

9,099

15/12/22

$0.00

15/12/25

None

6,962

15/12/23

$0.00

15/12/24

None

6,961

15/12/23

$0.00

15/12/25

None

6,961

15/12/23

$0.00

15/12/26

None

Annabelle Bexiga

658

04/03/22

$0.00

04/03/25

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

1,766

27/02/24

$0.00

27/02/25

None

Diane L Cooper

78

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

72

29/04/22

$0.00

29/04/25

None

57

29/07/22

$0.00

29/07/25

None

53

31/10/22

$0.00

31/10/24

None

52

31/10/22

$0.00

31/10/25

None

58

31/01/23

$0.00

31/01/25

None

58

31/01/23

$0.00

31/01/26

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

52

28/04/23

$0.00

28/04/25

None

52

28/04/23

$0.00

28/04/26

None

55

31/07/23

$0.00

31/07/25

None

54

31/07/23

$0.00

31/07/26

None

55

31/10/23

$0.00

31/10/24

None

52

31/10/23

$0.00

31/10/25

None

52

31/10/23

$0.00

31/10/26

None

1,766

27/02/24

$0.00

27/02/25

None

John M Fowler

60

29/10/21

$0.00

29/10/24

None

61

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

57

29/04/22

$0.00

29/04/25

None

45

29/07/22

$0.00

29/07/25

None

42

31/10/22

$0.00

31/10/24

None

42

31/10/22

$0.00

31/10/25

None

70

31/01/23

$0.00

31/01/25

None

69

31/01/23

$0.00

31/01/26

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

63

28/04/23

$0.00

28/04/25

None

61

28/04/23

$0.00

28/04/26

None

66

31/07/23

$0.00

31/07/25

None

66

31/07/23

$0.00

31/07/26

None

64

31/10/23

$0.00

31/10/24

None

63

31/10/23

$0.00

31/10/25

None

63

31/10/23

$0.00

31/10/26

None

62

31/01/24

$0.00

31/01/25

None

62

31/01/24

$0.00

31/01/26

None

61

31/01/24

$0.00

31/01/27

None

1,766

27/02/24

$0.00

27/02/25

None

62

30/04/24

$0.00

30/04/25

None

61

30/04/24

$0.00

30/04/26

None

61

30/04/24

$0.00

30/04/27

None

55

31/07/24

$0.00

31/07/25

None

55

31/07/24

$0.00

31/07/26

None

55

31/07/24

$0.00

31/07/27

None

Steven Kass

87

29/10/21

$0.00

29/10/24

None

93

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

87

29/04/22

$0.00

29/04/25

None

69

29/07/22

$0.00

29/07/25

None

63

31/10/22

$0.00

31/10/24

None

61

31/10/22

$0.00

31/10/25

None

70

31/01/23

$0.00

31/01/25

None

69

31/01/23

$0.00

31/01/26

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

63

28/04/23

$0.00

28/04/25

None

61

28/04/23

$0.00

28/04/26

None

66

31/07/23

$0.00

31/07/25

None

66

31/07/23

$0.00

31/07/26

None

64

31/10/23

$0.00

31/10/24

None

63

31/10/23

$0.00

31/10/25

None

63

31/10/23

$0.00

31/10/26

None

62

31/01/24

$0.00

31/01/25

None

62

31/01/24

$0.00

31/01/26

None

61

31/01/24

$0.00

31/01/27

None

1,766

27/02/24

$0.00

27/02/25

None

62

30/04/24

$0.00

30/04/25

None

61

30/04/24

$0.00

30/04/26

None

61

30/04/24

$0.00

30/04/27

None

55

31/07/24

$0.00

31/07/25

None

55

31/07/24

$0.00

31/07/26

None

55

31/07/24

$0.00

31/07/27

None

Eric Parthemore

87

29/10/21

$0.00

29/10/24

None

93

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

87

29/04/22

$0.00

29/04/25

None

69

29/07/22

$0.00

29/07/25

None

63

31/10/22

$0.00

31/10/24

None

61

31/10/22

$0.00

31/10/25

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

1,766

27/02/24

$0.00

27/02/25

None

John Radziwill

108

29/10/21

$0.00

29/10/24

None

117

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

108

29/04/22

$0.00

29/04/25

None

85

29/07/22

$0.00

29/07/25

None

78

31/10/22

$0.00

31/10/24

None

78

31/10/22

$0.00

31/10/25

None

87

31/01/23

$0.00

31/01/25

None

87

31/01/23

$0.00

31/01/26

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

78

28/04/23

$0.00

28/04/25

None

78

28/04/23

$0.00

28/04/26

None

82

31/07/23

$0.00

31/07/25

None

82

31/07/23

$0.00

31/07/26

None

80

31/10/23

$0.00

31/10/24

None

79

31/10/23

$0.00

31/10/25

None

79

31/10/23

$0.00

31/10/26

None

77

31/01/24

$0.00

31/01/25

None

77

31/01/24

$0.00

31/01/26

None

77

31/01/24

$0.00

31/01/27

None

1,766

27/02/24

$0.00

27/02/25

None

77

30/04/24

$0.00

30/04/25

None

77

30/04/24

$0.00

30/04/26

None

77

30/04/24

$0.00

30/04/27

None

69

31/07/24

$0.00

31/07/25

None

69

31/07/24

$0.00

31/07/26

None

69

31/07/24

$0.00

31/07/27

None

Dr Dhamu Thamodaran

292

29/10/21

$0.00

29/10/24

None

78

31/01/22

$0.00

31/01/25

None

658

04/03/22

$0.00

04/03/25

None

72

29/04/22

$0.00

29/04/25

None

57

29/07/22

$0.00

29/07/25

None

53

31/10/22

$0.00

31/10/24

None

52

31/10/22

$0.00

31/10/25

None

58

31/01/23

$0.00

31/01/25

None

58

31/01/23

$0.00

31/01/26

None

496

01/03/23

$0.00

01/03/25

None

495

01/03/23

$0.00

01/03/26

None

52

28/04/23

$0.00

28/04/25

None

52

28/04/23

$0.00

28/04/26

None

55

31/07/23

$0.00

31/07/25

None

54

31/07/23

$0.00

31/07/26

None

55

31/10/23

$0.00

31/10/24

None

52

31/10/23

$0.00

31/10/25

None

52

31/10/23

$0.00

31/10/26

None

51

31/01/24

$0.00

31/01/25

None

51

31/01/24

$0.00

31/01/26

None

51

31/01/24

$0.00

31/01/27

None

1,766

27/02/24

$0.00

27/02/25

None

50

30/04/24

$0.00

30/04/25

None

50

30/04/24

$0.00

30/04/26

None

50

30/04/24

$0.00

30/04/27

None

45

31/07/24

$0.00

31/07/25

None

45

31/07/24

$0.00

31/07/26

None

44

31/07/24

$0.00

31/07/27

None

 

All grants are made at $0.00 and then reflected as ordinary income upon vesting.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c)        Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

YES

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 October 2024

Contact name:

Diego Rotsztain

Telephone number:

+1 917 399 7248

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .



SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

StoneX Group Inc. on behalf of Sean O'Connor as a concert party

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

StoneX Group Inc.

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date








 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

Sean O'Connor, a party acting in concert with StoneX Group Inc. ("StoneX"), has entered into a 10b5-1 plan pursuant to which common shares of StoneX which are currently owned by him will be automatically sold by a broker on the open market if such shares reach a specified trigger price during the relevant date range. The common shares which are subject to the 10b5-1 plan are included in the shareholding figure for Sean O'Connor at item 3(a) of StoneX's Form 8 (OPD). Details of the 10b5-1 plan are set out in the table below.

 

Name

No. of common shares in StoneX Group Inc. subject to plan*

Date range

Trigger Price

Sean O'Connor

37,500

13/03/24 - 31/12/24

$98.00

Sean O'Connor

37,500

13/03/24 - 31/12/24

$115.00

Sean O'Connor

37,500

13/03/24 - 31/12/24

$130.00

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEMZMZGFFLGDZM